Although Tau dysfunction is canonically associated with neurodegenerative disease (e.g., Alzheimer’s disease), converging evidence indicates that Tau phosphorylation is also implicated in neurodevelopmental disorders. This evidence concerns the gene MAPT and neurodegenerative disease.